Preeclampsia, a hypertensive disorder affecting 3–5% of pregnancies, poses significant risks to both mother and baby. Despite its global prevalence, predicting and preventing preeclampsia remains challenging due to limited accuracy of known risk factors and only moderately effective preventive therapies. This condition is a leading cause of maternal morbidity and contributes to serious fetal complications such as intrauterine growth restriction, preterm birth, and stillbirth. Guidelines for fetal surveillance vary widely, reflecting a lack of strong evidence on optimal assessment methods and timing. Current fetal management focuses on timely delivery and minimizing prematurity risks using corticosteroids and magnesium sulfate. Emerging data also link preeclampsia to long-term cardiovascular effects in offspring, including hypertension and vascular dysfunction.
Select Content Type
Resources
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Detail Image
Book Detail
Upload PDF
Preeclampsia.pdf
(733.1 KB)
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description